Search

Your search keyword '"Afeltra, Antonella"' showing total 528 results

Search Constraints

Start Over You searched for: Author "Afeltra, Antonella" Remove constraint Author: "Afeltra, Antonella"
528 results on '"Afeltra, Antonella"'

Search Results

201. Nutritional status measured by BMI is impaired and correlates with left ventricular mass in patients with systemic sclerosis.

202. An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab

203. Erectile Dysfunction, Endothelium Dysfunction, and Microvascular Damage in Patients with Systemic Sclerosis.

204. Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.

205. Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance.

206. Evaluation of Current Methods for the Measurement of Serum Anti–Double-Stranded DNA Antibodies.

207. Portal Diameter in the Diagnosis of Esophageal Varices in 266 Cirrhotic Patients: Which Role?

208. Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates.

209. Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs

210. Screening of antinuclear antibodies: comparison between enzyme immunoassay based on nuclear homogenates, purified or recombinant antigens and immunofluorescence assay.

211. Antibodies to anionic phospholipids and anti-β2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus

212. Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis

213. Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study

214. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids

215. Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis

216. Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register

217. Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study

218. The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study

219. JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies.

220. International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management

221. Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study

222. Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study

223. Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients.

225. Serum osteopontin negatively impacts on intima‐media thickness in patients with systemic lupus erythematosus.

226. Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study

227. Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study.

228. Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey.

229. Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis.

230. Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis.

231. Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study.

232. The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus.

233. Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment.

234. One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study.

235. Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort.

236. Serum adiponectin levels are associated with presence of carotid plaque in women with systemic lupus erythematosus.

237. Phase angle could be a marker of microvascular damage in systemic sclerosis.

238. Omalizumab in eosinophilic granulomatosis with polyangiitis: friend or foe? A systematic literature review.

239. An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab.

240. Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy.

241. Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

242. Inflammation and Dysmetabolism in Systemic Autoimmune Diseases.

243. Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis.

244. Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints.

245. Fatigue in systemic sclerosis: a systematic review.

246. Differences in carotid atherosclerosis between patients with ankylosing spondylitis treated with tumor necrosis factor-α antagonists and healthy matched controls.

247. Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis.

248. Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review.

249. Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

250. Levels of Vitamin D, Disease Activity and Subclinical Atherosclerosis in Post-menopausal Women with Sjögren's Syndrome: Does a Link Exist?

Catalog

Books, media, physical & digital resources